An intelligent cold chain logistics warehousing management system based on big data

Abstract

The present application relates to the field of warehousing and logistics technology, and in particular to an intelligent management system for cold chain logistics warehousing based on big data. The system includes: obtaining and analyzing the loading plan, determining the drug information and warehouse information; analyzing the drug information to determine the suitable storage temperature; analyzing the drug information, the warehouse information and the suitable storage temperature to determine the non-cold chain environment warranty period of the drug; determining the vehicle information based on the suitable storage temperature and the drug information; formulating a loading strategy based on the drug information, the warehouse information, the vehicle information and the non-cold chain environment warranty period for reference by cold chain logistics warehousing management personnel. By comprehensively analyzing information such as drugs, warehouses, and vehicles, a scientific loading strategy is formulated, aiming to improve the efficiency of cold chain logistics, ensure the quality of drugs, optimize resource allocation, and provide decision-making support for managers, thereby improving customer satisfaction and overall operational levels.

Description

Technical Field

[0001] The present application relates to the field of warehousing and logistics technology, and in particular to an intelligent cold chain logistics warehousing management system based on big data. Background Art

[0002] The cold chain logistics warehouse management system is a warehouse management system specifically for the cold chain logistics process, which aims to comprehensively monitor and manage environmental factors such as temperature and humidity during the cold chain logistics process. The current mainstream method is to monitor and manage goods through sensors with IoT functions to monitor goods information.

[0003] The existing cold chain logistics warehousing intelligent management system is still unable to provide good comprehensive monitoring and timely management for medicines that have strict requirements when loading and unloading in warehouses. This can easily lead to the medicines failing to meet the storage requirements due to temperature changes, resulting in quality changes and causing huge losses. Summary of the invention

[0004] The present application provides a cold chain logistics warehousing intelligent management system based on big data to solve the above problems.

[0005] In a first aspect, the present application provides a cold chain logistics warehousing intelligent management system based on big data, the system comprising:

[0006] Obtain and analyze the stocking plan, and determine drug information and warehouse information;

[0007] Analyze the drug information and determine the appropriate storage temperature;

[0008] Analyze the drug information, the warehouse information and the suitable storage temperature to determine the non-cold chain environment warranty period of the drug;

[0009] Determining vehicle information according to the suitable storage temperature and the drug information;

[0010] According to the drug information, the warehouse information, the vehicle information and the non-cold chain environment warranty period, a loading strategy is formulated for reference by cold chain logistics warehousing management personnel.

[0011] Through the above technical solution, according to the loading plan, the drug information and the warehouse information of the loading are determined, and the suitable storage temperature of the drug is determined by analyzing the drug information and warehouse information. By determining the suitable storage temperature of the drug, the necessary data basis is provided for the subsequent formulation of the loading strategy. Then, according to the drug information, warehouse information and the suitable storage temperature of the drug, the quality assurance time of the drug in the non-cold chain environment is obtained. In the subsequent loading, it can be clearly known within how much time the drug needs to be transported to avoid the situation where the drug stays in the non-cold chain environment for too long and the efficacy changes. And according to the suitable storage temperature of the drug and the information of the drug, the vehicle information is determined, and then according to the drug information, warehouse information, vehicle information and the quality assurance time of the non-cold chain environment, the loading strategy is formulated. By accurately matching the suitable storage temperature of the drug and the vehicle temperature conditions, as well as the quality assurance time of the drug in the non-cold chain environment, it is ensured that the drug is at the suitable storage temperature of the drug throughout the process, thereby ensuring the efficacy of the drug. In addition, the formulation of the loading strategy also improves the efficiency of the entire cold chain vehicle dispatching and ensures the timely transportation of drugs.

[0012] Optionally, analyzing the drug information, the warehouse information, and the suitable storage temperature to determine the non-cold chain environment quality assurance period of the drug includes:

[0013] According to the warehouse information, non-refrigerated area information is obtained;

[0014] Analyze the non-refrigerated area information to determine the temperature of the non-refrigerated area;

[0015] Determine the main ingredients of the drug based on the drug information;

[0016] Analyze the temperature of the non-refrigerated area, the main ingredients of the medicine and the suitable storage temperature to determine the shelf life of the medicine in a non-cold chain environment.

[0017] Through the above technical scheme, the warehouse information is used to obtain the non-refrigerated area information in the warehouse, and then the non-refrigerated area information is analyzed to determine the temperature of the non-refrigerated area, and then the main ingredients of the medicine are determined according to the medicine information. Finally, the non-cold chain environment quality assurance period of the medicine is determined by combining the analysis of the non-refrigerated area information, the main ingredients of the medicine and the suitable storage temperature of the medicine. The whole process realizes the temperature monitoring of the non-refrigerated area, ensures the accuracy and real-time of the temperature, avoids the errors of manual operation, obtains the medicine ingredients, and ensures that the subsequent evaluation of the non-cold chain environment quality assurance period of the medicine ingredients is more accurate, so that the determination of the non-cold chain environment quality assurance period has sufficient information support, thereby improving the level of medicine safety assurance.

[0018] Optionally, determining vehicle information according to the suitable storage temperature and the drug information includes:

[0019] According to the drug information, obtain drug quantity and drug packaging information;

[0020] Determining the number of medicines according to the quantity of the medicines and the packaging information of the medicines;

[0021] Determine the size of a single piece of medicine according to the medicine packaging information;

[0022] The vehicle information is determined based on the number of medicines, the suitable storage temperature and the size of each medicine.

[0023] Through the above technical solution, the drug quantity and drug packaging information are obtained according to the drug information. The total number of drugs is determined through the drug quantity and drug packaging information, and the size of each drug is determined through the drug packaging information. Finally, the vehicle information is determined using the number of drugs, the size of each drug and the appropriate storage temperature of the drugs. Through multi-dimensional data analysis, the accuracy of vehicle information is ensured, the utilization efficiency of vehicles is improved, and a scientific strategy is provided for the subsequent arrangement of vehicles.

[0024] Optionally, determining the vehicle information according to the number of medicines, the suitable storage temperature and the size of each medicine includes:

[0025] Determine the volume of a single medicine according to the size of the single medicine;

[0026] Determining suitable storage vehicle information according to the suitable storage temperature;

[0027] Determine the number of pieces loaded on each suitable storage vehicle according to the suitable storage vehicle information and the size of the medicine pieces;

[0028] According to the volume of the single medicine and the number of medicines loaded on each suitable storage vehicle, the best vehicle is selected from the suitable storage vehicle information, and the best vehicle information is extracted;

[0029] Determining the number of vehicles according to the number of medicines and the number of loaded medicines of the optimal vehicle;

[0030] The vehicle information is determined according to the optimal vehicle information and the number of vehicles.

[0031] Through the above technical scheme, after the volume of a single medicine is calculated according to the size of a single medicine, a suitable vehicle is screened out according to the suitable storage temperature of the medicine, and the number of pieces loaded in a vehicle is calculated according to the vehicle information. Then, according to the volume of a single medicine and the number of pieces loaded, the suitable vehicle with the highest space utilization is determined as the best vehicle, and the number of vehicles is determined according to the number of medicines and the number of pieces loaded. The best vehicle information and the number of vehicles are determined as vehicle information. By selecting a suitable vehicle, it is ensured that the vehicle can provide the suitable storage temperature required for the medicine, and then by calculating the space utilization rate, it is ensured that the transportation vehicle resources are highly utilized, saving transportation costs.

[0032] Optionally, the analyzing the temperature of the non-refrigerated area, the main ingredients of the drug and the suitable storage temperature to determine the non-cold chain environment quality assurance period of the drug includes:

[0033] Determine the proportion of the main ingredients of the drug based on the drug information;

[0034] Analyze the main components of the drug and determine the composition characteristics of each main component of the drug;

[0035] Analyze the composition characteristics to determine the temperature variation properties of each major component of the drug;

[0036] Based on the characteristics of the ingredients, determine whether any two main ingredients of the drug have properties that affect each other;

[0037] If it exists, the temperature change property of the drug is determined according to the temperature change property of each main component of the drug, the component ratio and the mutual influence property of any two main components of the drug, referring to the following formula:

[0038]

[0039] Among them, V mix is the temperature change property of the drug, v i is the temperature variation property of the main component of the i-th drug, p i is the proportion of the main ingredient of the i-th drug in the drug, n is the total number of main ingredients of the drug, A is the interaction matrix, A ij is the interaction property between the main components of the ith drug and the jth drug; p j is the proportion of the main ingredient of the jth drug in the drug;

[0040] Analyze the temperature of the non-refrigerated area and the temperature change properties of the medicine to determine the non-cold chain environment quality assurance period of the medicine.

[0041] Through the above technical solution, the main components of the drug are deeply analyzed, the temperature change properties of the main components of the drug are obtained, and then the mutual influence properties between the main components of the drug are obtained. By obtaining the mutual influence properties between the main components of the drug, it can help to more accurately determine the temperature change properties of the drug, and help prevent the components from reacting with each other, thereby avoiding drug safety problems. Using the designed mathematical formula, the temperature change properties of the drug are calculated based on the temperature change properties of each main component of the drug, the component ratio and the mutual influence properties of any two main components of the drug, and then the temperature change properties of the drug are combined with the non-cold chain environment temperature to provide an accurate scientific basis for obtaining the non-cold chain environment quality assurance time of the drug, which is convenient for the scheduling of drugs during subsequent loading.

[0042] Optionally, the vehicle information further includes vehicle geographic location information, and the formulating of a loading strategy based on the drug information, the warehouse information, the vehicle information and the non-cold chain environment warranty period includes:

[0043] According to the warehouse information, obtain the warehouse geographical location information;

[0044] Determining path planning information according to the vehicle geographic location information and the warehouse geographic location information;

[0045] Analyze the path planning information according to the optimal vehicle information to determine the time when the vehicle arrives at the warehouse;

[0046] A loading strategy is formulated based on the drug information, the warehouse information, the vehicle arrival time at the warehouse and the non-cold chain environment warranty period.

[0047] Through the above technical solution, the geographical location of the warehouse is first determined based on the warehouse information, and then the path planning information is determined based on the geographical location of the vehicle and the warehouse, which reduces the time the vehicle is on the road, thereby speeding up the logistics speed and improving the overall logistics efficiency. Then, based on the best vehicle information and combined with the path planning information, the actual path situation is obtained to ensure that the accurate vehicle arrival time at the warehouse is obtained. According to the vehicle arrival time, the warehouse can prepare in advance to ensure that the vehicle can be loaded immediately after arrival. Comprehensive drug information, warehouse information, vehicle arrival time and non-cold chain environment warranty time are used to formulate an efficient loading strategy, making the entire loading process more smooth.

[0048] Optionally, after formulating the loading strategy according to the drug information, the warehouse information, the time when the vehicle arrives at the warehouse and the non-cold chain environment warranty period, the method further includes:

[0049] Determine the destination of drug delivery according to the drug information;

[0050] Determine the vehicle transportation starting point and the vehicle transportation end point according to the warehouse geographical location information and the drug delivery destination;

[0051] Determine each feasible route according to the vehicle transportation starting point and the vehicle transportation end point;

[0052] According to each feasible route, extracting route information of each feasible route;

[0053] Analyze the route information to determine the route distance and route conditions;

[0054] Analyze the road conditions of the route to determine the bumpiness of the route;

[0055] Analyze the bumps on the route to determine the effect of the feasible route on the temperature of the drug;

[0056] According to the temperature influence, the feasible routes are screened to obtain a suitable route;

[0057] Determine the travel time of the suitable route according to the route distance and route conditions of each suitable route;

[0058] The route information of the suitable route with the shortest travel time is used as the transportation route planning information.

[0059] Through the above technical scheme, the drug delivery destination is first obtained through the drug, and then the warehouse location is used as the transportation starting point and the drug delivery destination as the transportation end point. All passable routes are screened out, and the impact of the bumps on the drug temperature is determined in combination with the bumps on the route. The route with good bumps is selected, and the transportation time is calculated based on the route distance and route conditions. The route with the shortest transportation time is used as the transportation route. By considering the impact of route bumps on temperature, the situation in which the drug temperature fluctuates greatly due to route reasons and thus changes in quality during the transportation process is avoided, and a route with a shorter travel time is selected from the appropriate routes, making the entire transportation more reliable and faster, and avoiding the risk of chain breaks due to transportation route factors as much as possible, providing a scientific strategy for transportation route planning.

[0060] Optionally, formulating a loading strategy according to the drug information, the warehouse information, the time when the vehicle arrives at the warehouse, and the non-cold chain environment warranty period includes:

[0061] According to the warehouse information, determine the total personnel information and total equipment information of the warehouse;

[0062] Analyze the total personnel information and the total equipment information of the warehouse to obtain personnel tasks and equipment tasks;

[0063] According to the personnel tasks and the device tasks, determine the personnel information and device information used for this shipment;

[0064] Analyze the personnel information and the drug information to determine the personnel's unloading capacity;

[0065] Analyze the device information to determine the number and size of devices;

[0066] Determine the warehouse outbound capacity based on the personnel unloading capacity, the number of devices, the device size and the size of the drug unit, referring to the following formula:

[0067]

[0068] Among them, B is the warehouse outbound capacity, α is the connection rate coefficient between people and equipment, C is the personnel unloading capacity, M is the number of equipment, Sd is the size of a single device, S g The size of a single drug item;

[0069] A loading strategy is formulated based on the personnel information, the warehouse's outbound capacity, the vehicle's arrival time, and the non-cold chain environment warranty period.

[0070] Through the above technical solution, we first obtain the total personnel information and total equipment information of the warehouse, and then determine the personnel and equipment that can be used for loading the goods this time according to the task information of each personnel and each equipment, which provides a data basis for the subsequent calculation of the warehouse outbound capacity. By using the personnel unloading capacity, the number of equipment, the size of the equipment and the size of the single medicine, the warehouse outbound capacity is calculated using mathematical formulas, which can accurately grasp the warehouse outbound capacity and provide reasonable basic information for subsequent coordination with vehicles. According to the arrival time of the vehicle, when to start moving the goods is calculated in advance before the vehicle arrives, so that the vehicle does not wait for the goods, and the goods do not wait for the vehicle after leaving the cold storage.

[0071] Optionally, analyzing the personnel information and the drug information to determine personnel unloading capacity includes:

[0072] Determining the quality of a single drug according to the drug information and the drug packaging information;

[0073] Determine the number of people loading each item according to the volume of the item, the weight of the item and the personnel information;

[0074] Determine the total number of people loading goods based on the personnel information;

[0075] Determine the unloading capacity of personnel based on the total number of people loading goods and the number of people loading each piece of goods, referring to the following formula:

[0076]

[0077] Among them, C is the unloading capacity of personnel, N is the total number of people loading goods, and n p The number of people loading a single item.

[0078] Through the above technical scheme, the unit mass of the drugs is first obtained according to the drug information, and then the number of drugs in each piece is obtained through the drug packaging information, so as to determine the mass of the single drug. The mass of the single drug is combined with the volume of the single drug, and the human factor is considered to determine how many people are needed to load one piece of goods. This is conducive to avoiding waste of human resources and improving transportation efficiency. Finally, according to the total number of people loading goods, the unloading capacity of the personnel is calculated using mathematical formulas, and the abstract transportation capacity is concretized, which provides direct data for measuring the unloading capacity. Flexible arrangements can also be made for different goods, and the most reasonable personnel arrangements can be made regardless of the size and weight of the goods.

[0079] Optionally, determining the number of people loading a single piece of medicine according to the volume of the single piece of medicine, the mass of the single piece of medicine and the personnel information includes:

[0080] Determine the maximum volume and the maximum mass that can be carried by a single person based on the personnel information;

[0081] According to the maximum volume, the maximum mass, the volume of a single drug item and the mass of a single drug item, determine the number of people loading a single item, referring to the following formula:

[0082]

[0083] Among them, n p is the number of people loading a single piece of goods, V max is the maximum volume that a single person can carry, v is the volume of a single medicine, M max is the maximum mass that can be carried by a single person, and m is the volume of a single piece of medicine.

[0084] Through the above technical solution, firstly, the maximum volume and the maximum mass that can be carried by a single person are determined based on the personnel information. Then, the volume and mass of a single medicine are taken into consideration to determine the number of people loading a single piece of medicine. By using mathematical formulas, personnel can be accurately arranged, which can avoid both waste of human resources and the danger of overload of personnel. BRIEF DESCRIPTION OF THE DRAWINGS

[0085] In order to more clearly illustrate the embodiments of the present application or the technical solutions in the prior art, a brief introduction will be given below to the drawings required for use in the embodiments or the description of the prior art. Obviously, the drawings described below are some embodiments of the present application. For ordinary technicians in this field, other drawings can be obtained based on these drawings without paying any creative labor.

[0086] Figure 1 A schematic diagram of an application scenario provided for an embodiment of the present application;

[0087] Figure 2 A flowchart of a cold chain logistics warehousing intelligent management system based on big data provided in one embodiment of the present application; DETAILED DESCRIPTION

[0088] In order to make the purpose, technical scheme and advantages of the embodiments of the present application clearer, the technical scheme in the embodiments of the present application will be clearly and completely described below in conjunction with the drawings in the embodiments of the present application. Obviously, the described embodiments are part of the embodiments of the present application, not all of the embodiments. Based on the embodiments in the present application, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of this application.

[0089] In addition, the term "and / or" in this article is only a description of the association relationship of associated objects, indicating that there can be three relationships. For example, A and / or B can represent: A exists alone, A and B exist at the same time, and B exists alone. In addition, the character " / " in this article, unless otherwise specified, generally means that the associated objects before and after are in an "or" relationship.

[0090] The embodiments of the present application are further described in detail below in conjunction with the drawings in the specification.

[0091] The existing cold chain logistics warehousing intelligent management system configures a cold chain environment during warehousing and transportation to ensure the quality of goods according to the appropriate storage temperature of the goods. However, in the process from warehousing to transportation, the refrigeration conditions cannot be guaranteed. For medicines with strict temperature requirements, it is very easy to cause chain breaks, which will change the efficacy of the medicines or even make them ineffective.

[0092] Based on this, the present application provides a cold chain logistics warehousing intelligent management system based on big data. According to the loading plan, the drug information and the warehouse information where the loading is located are determined. By analyzing the drug information, the suitable storage temperature of the drug is determined. Then the warehouse information is analyzed to determine the warehouse environment information. The suitable storage temperature of the drug and the warehouse environment information are combined with the drug information to obtain the shelf life of the drug in a non-cold chain environment. The non-cold chain environment shelf life is obtained to provide basic information for the subsequent planning of the process of loading the drug from the warehouse to the vehicle, and the vehicle information is determined based on the suitable storage temperature of the drug and the drug information. Then, based on the drug information, warehouse information, vehicle information and non-cold chain environment shelf life, a loading strategy is formulated. Through the system provided by this application, starting from the loading plan, the corresponding drug information and warehouse information are obtained, and the loading strategy is intelligently formulated to avoid the situation where the drug stays in the non-cold chain environment for too long during the loading process due to inaccurate and inefficient loading strategies, resulting in changes in drug efficacy.

[0093] Figure 1 A schematic diagram of an application scenario provided for this application. When loading medicines from a cold storage to a transport vehicle, the method provided by this application is applied to formulate different loading strategies based on the loading plan to ensure that there is no interruption in the loading process.

[0094] Specifically, the method provided in the present application is applied to any server, and the server interacts with the cold chain logistics warehousing order management system.

[0095] The server obtains and analyzes the loading plan from the cold chain logistics warehousing order management system, determines the drug information and warehouse information, analyzes the drug information, determines the appropriate storage temperature, and determines the non-cold chain environment warranty time of the drug based on the drug information, warehouse information and the appropriate storage temperature. Then, based on the appropriate storage temperature and drug information, the server determines the vehicle information. Finally, based on the drug information, warehouse information, vehicle information and non-cold chain environment warranty time, the server formulates a loading strategy for reference by cold chain logistics warehousing management personnel, so that different loading strategies can be customized according to different drugs to avoid drug chain breaks during the cold chain logistics warehousing management process due to the loading strategy not being suitable for the current drug, thereby changing the drug efficacy.

[0096] For specific implementation methods, please refer to the following embodiments.

[0097] Figure 2 This is a flowchart of a cold chain logistics warehousing management system based on big data provided by an embodiment of the present application. The system of this embodiment can be applied to the servers in the above scenarios. Figure 2 As shown, the method includes:

[0098] S201. Obtain and analyze the stocking plan, and determine the drug information and warehouse information.

[0099] The loading plan can be a drug shipment plan based on customer requirements.

[0100] The drug information may be the drug information required by the customer this time, and the drug information may include the main ingredients of the drug, the quantity of the drug, the drug packaging information, and the suitable storage temperature of the drug.

[0101] The warehouse information may be the warehouse information of the location where the medicine is loaded this time, and the warehouse information may include non-refrigerated area information, warehouse geographical location information, total warehouse personnel information, and total warehouse equipment information.

[0102] Specifically, after formulating a stocking plan according to customer requirements, the natural language processing technology is used to analyze the stocking plan, obtain the content of the stocking plan, and extract key content, such as the drug information and warehouse information of this stocking.

[0103] S202: Analyze the drug information and determine the appropriate storage temperature.

[0104] The suitable storage temperature can be the ambient temperature in which the medicine is stored during the storage and transportation process in order to ensure that the efficacy of the medicine does not change. This ambient temperature can be a temperature range.

[0105] Specifically, after determining the drug information, obtain the drug's instructions for use, analyze the instructions through natural language processing technology, obtain the drug's storage conditions from the instructions for use, and obtain the drug's appropriate storage temperature from the storage conditions.

[0106] S203: Analyze the drug information, the warehouse information and the suitable storage temperature to determine the drug's non-cold chain environment warranty period.

[0107] The non-cold chain environment shelf life of drugs can be the maximum storage time allowed for drugs that require cold chain storage in an environment that does not reach the appropriate storage temperature.

[0108] Specifically, through natural language processing technology, we analyze drug information and determine the main ingredients of the drugs. Based on the warehouse information, we determine the impact of the warehouse on the drugs. Combined with the main ingredients of the drugs, the impact of the warehouse on the drugs, and the suitable storage temperature of the drugs, we use mathematical analysis to determine the maximum time that the drugs are allowed to be stored in an environment where the suitable storage temperature is not reached, that is, the warranty time in a non-cold chain environment.

[0109] S204. Determine vehicle information based on the suitable storage temperature and the drug information.

[0110] The vehicle information may be the vehicle information used for this drug delivery plan, and the vehicle information includes vehicle size, vehicle compartment temperature, optimal vehicle, number of vehicles, etc.

[0111] Specifically, the best vehicle and the number of vehicles are determined based on the appropriate storage temperature of the medicines and the medicine information, thereby determining the vehicle information.

[0112] S205. Formulate a loading strategy based on the drug information, the warehouse information, the vehicle information and the non-cold chain environment warranty period for reference by cold chain logistics warehousing management personnel.

[0113] Specifically, when shipment is required, the drug information, warehouse information, vehicle information and non-cold chain environment warranty time are integrated, and a loading strategy is formulated through mathematical analysis. The strategy is provided to cold chain logistics warehousing management personnel for reference, so that reasonable arrangements can be made and loading efficiency can be improved.

[0114] Through the method provided in this embodiment, according to the loading plan, the drug information of the loading and the warehouse information where the loading is located are determined, and the suitable storage temperature of the drug is determined by analyzing the drug information and the warehouse information. By determining the suitable storage temperature of the drug, the necessary data basis is provided for the subsequent formulation of the loading strategy. According to the drug information, warehouse information and the suitable storage temperature of the drug, the quality assurance time of the drug in a non-cold chain environment is obtained. In the subsequent loading, it can be clearly known within how much time the drug needs to be transported to avoid the situation where the drug is detained in the non-cold chain environment for too long and the efficacy changes. And according to the suitable storage temperature of the drug and the information of the drug, the vehicle information is determined, and then according to the drug information, warehouse information, vehicle information and the quality assurance time of the non-cold chain environment, the loading strategy is formulated. By accurately matching the suitable storage temperature of the drug and the vehicle temperature conditions, as well as the quality assurance time of the drug in the non-cold chain environment, it is ensured that the drug is at the suitable storage temperature of the drug throughout the process, thereby ensuring the efficacy of the drug. In addition, the formulation of the loading strategy also improves the efficiency of the entire cold chain vehicle dispatching and ensures the timely transportation of drugs.

[0115] In some embodiments, non-refrigerated area information is obtained based on warehouse information; the non-refrigerated area information is analyzed to determine the temperature of the non-refrigerated area; the main ingredients of the drug are determined based on the drug information; the non-refrigerated area temperature, the main ingredients of the drug and the suitable storage temperature are analyzed to determine the non-cold chain environment quality assurance period of the drug.

[0116] The non-refrigerated area information may be area information in the warehouse excluding the cold storage where medicines are stored, and the non-refrigerated area information includes the temperature of the non-refrigerated area.

[0117] The temperature of the non-refrigerated area can be the ambient temperature of the area in the warehouse excluding the cold storage where medicines are stored.

[0118] The main ingredient of a drug can be the main ingredient that constitutes the drug and has medical effects. It can be a single compound or multiple compounds. In a specific implementation, various drugs and their drug information are stored in a drug database, and the main ingredient of the drug can be obtained by querying the drug information in the drug database.

[0119] Specifically, first determine the area information of the warehouse excluding the cold storage where medicines are stored through the warehouse information, and use the temperature sensor to extract the ambient temperature of this area as the non-refrigerated area temperature. According to the medicine information, obtain the main ingredients of the medicine by querying the medicine database, and comprehensively consider the non-refrigerated area temperature, the main ingredients of the medicine and the suitable storage temperature of the medicine, and determine the non-cold chain environment warranty period of the medicine through mathematical analysis.

[0120] Through the method provided in this embodiment, the non-refrigerated area information in the warehouse is obtained through the warehouse information, and then the non-refrigerated area information is analyzed to determine the temperature of the non-refrigerated area, and then the main ingredients of the medicine are determined according to the medicine information. Finally, the non-cold chain environment warranty time of the medicine is determined by combining the analysis of the non-refrigerated area information, the main ingredients of the medicine and the suitable storage temperature of the medicine. The whole process realizes the temperature monitoring of the non-refrigerated area, ensures the accuracy and real-time of the temperature, avoids the errors of manual operation, obtains the medicine ingredients, and ensures that the subsequent evaluation of the non-cold chain environment warranty time of the medicine ingredients is more accurate, so that the determination of the non-cold chain environment warranty time has sufficient information support, thereby improving the level of medicine safety assurance.

[0121] In some embodiments, the drug quantity and drug packaging information are obtained based on the drug information; the number of drug pieces is determined based on the drug quantity and drug packaging information; the size of a single drug piece is determined based on the drug packaging information; and the vehicle information is determined based on the number of drug pieces, suitable storage temperature and the size of a single drug piece.

[0122] The quantity of medicines can be the quantity of medicines required in this delivery plan, and the quantity unit of the quantity of medicines can be one box or one bottle.

[0123] The drug packaging information may be the packaging information of the drugs that are being shipped this time, and the drug packaging information includes the size of a single drug piece, the drug packaging material, the drug packaging shape, and the like.

[0124] The number of medicines can be the number of packages of the medicines that are being loaded this time after packaging. The number of medicines is the minimum transport unit during transportation.

[0125] The size of a single piece of medicine may be the size of the medicine after it is packaged.

[0126] Specifically, firstly, based on the drug information, the quantity of drugs shipped out this time and the drug packaging information are obtained to determine the quantity of drugs needed for one packaging. Then, the number of drugs is divided by the number of drugs required for one piece to obtain the number of drugs after packaging. Then, based on the drug packaging information, the size of each drug piece is determined. Finally, based on the number of drugs, the size of each drug piece and the suitable storage temperature of the drugs, vehicles whose carriages can provide the suitable storage temperature for drugs are first selected. Then, the vehicle size and the number of vehicles are determined from these vehicles through calculation. The vehicle with the most matching vehicle size is taken as the best vehicle, and the information of the best vehicle is taken as the vehicle information.

[0127] Through the method provided in this embodiment, the drug quantity and drug packaging information are obtained based on the drug information. The total number of drugs is determined through the drug quantity and drug packaging information, and the size of each drug is determined through the drug packaging information. Finally, the vehicle information is determined using the number of drugs, the size of each drug and the appropriate storage temperature of the drugs. Through multi-dimensional data analysis, the accuracy of vehicle information is ensured, the utilization efficiency of vehicles is improved, and a scientific strategy is provided for the subsequent arrangement of vehicles.

[0128] In some embodiments, the volume of a single drug is determined based on its size; suitable storage vehicle information is determined based on a suitable storage temperature; the number of drugs that can be loaded on each suitable storage vehicle is determined based on the suitable storage vehicle information and the size of the drug; the best vehicle is selected from the suitable storage vehicle information based on the volume of a single drug and the number of drugs loaded on each suitable storage vehicle, and the best vehicle information is extracted; the number of vehicles is determined based on the number of drugs and the number of drugs loaded on the best vehicle; and vehicle information is determined based on the best vehicle information and the number of vehicles.

[0129] The volume of a single piece of medicine can be the volume of the medicine after packaging, and the volume of a single piece of medicine can be calculated based on the size of the single piece of medicine.

[0130] The suitable storage vehicle information may be the refrigerated vehicle information that can provide a suitable storage temperature for medicines.

[0131] The best vehicle information may be the vehicle information with the highest space utilization rate among the suitable storage vehicles for transporting the medicine.

[0132] The number of pieces loaded may be the number of pieces of medicine that the optimal vehicle can load at one time.

[0133] The number of vehicles may be the number of optimal vehicles participating in this loading.

[0134] Specifically, first, determine the shape of the drug packaging according to the drug packaging information, then calculate the volume of a single drug piece according to the drug packaging size using the volume calculation formula of the drug packaging shape, and then select a vehicle that can set the compartment temperature to the suitable storage temperature of the drug according to the suitable storage temperature of the drug as a suitable vehicle. Then, according to the size of a single drug piece and the volume of a single drug piece, select a compartment whose compartment size is close to an integer multiple of the size of a single drug piece from the suitable vehicles, then calculate the number of pieces loaded in these compartments, and then calculate the compartment volume through the compartment size, and multiply the volume of a single drug piece by the number of pieces loaded in the suitable vehicle to obtain the volume of drugs shipped by a vehicle, and divide the volume of drugs shipped by a vehicle by the compartment volume to obtain the space utilization rate of the compartment, and select the suitable vehicle with the largest space utilization rate as the best vehicle, and determine how many vehicles are needed according to the number of pieces loaded and the number of drugs in the best vehicle, and the calculation method can be divided by the number of drugs loaded and rounded up, and the best vehicle information and the number of vehicles are determined as vehicle information.

[0135] For example, the drug package is a cuboid with the dimensions of 1 meter long, 2 meters wide and 1 meter high. There are two suitable vehicles: one with a compartment of 9.2 meters long, 4.5 meters wide and 2 meters high (hereinafter referred to as Car A) and one with a compartment of 7.8 meters long, 3 meters wide and 1.5 meters high (hereinafter referred to as Car B). Car A can accommodate 9 pieces of medicine in length, 2 pieces of medicine in width and 2 pieces of medicine in height. Car A can carry 9×2×2 pieces of medicine, a total of 36 pieces of medicine, with a volume of 36×1×1×2, 72 cubic meters, and a compartment volume of 9.2×4.5×2, 82.8 cubic meters, and an empty compartment volume of 1.5 meters. The space utilization rate of carriage A is 87%. Similarly, the space utilization rate of carriage B is 40%. In this example, carriage A is determined as the best vehicle. The number of vehicles is determined based on the number of medicines and the number of pieces loaded in the best vehicle. The calculation method is number of medicines / number of pieces loaded in the best vehicle. The calculation result is rounded up to get the number of vehicles. For example, there are 100 pieces of medicines, and the best vehicle can transport 19 pieces of medicines. The number of vehicles required is 100 / 19 rounded up, which is 6. Therefore, 6 best vehicles are needed for this transportation. The best vehicle information and the number of vehicles of the best vehicle are determined as the vehicle information.

[0136] Through the method provided in this embodiment, after the volume of a single drug is calculated based on the size of a single drug, a suitable vehicle is screened out based on the suitable storage temperature of the drug, and the number of loads of a vehicle is calculated based on the vehicle information. Then, based on the volume of a single drug and the number of loads, the suitable vehicle with the highest space utilization is determined as the best vehicle, and the number of vehicles is determined based on the number of drug pieces and the number of loads. The best vehicle information and the number of vehicles are determined as vehicle information. By selecting a suitable vehicle, it is ensured that the vehicle can provide the suitable storage temperature required for the drugs. Then, by calculating the space utilization, it is ensured that the transportation vehicle resources are highly utilized, saving transportation costs.

[0137] In some embodiments, based on the drug information, the proportion of the main ingredients of the drug is determined; the main ingredients of the drug are analyzed to determine the ingredient characteristics of each main ingredient of the drug; the ingredient characteristics are analyzed to determine the temperature change properties of each main ingredient of the drug; based on the ingredient characteristics, it is determined whether any two main ingredients of the drug have mutual influence properties; if so, the temperature change properties of the drug are determined based on the temperature change properties of each main ingredient of the drug, the ingredient ratio and the mutual influence properties of any two main ingredients of the drug; the temperature of the non-refrigerated area and the temperature change properties of the drug are analyzed to determine the non-cold chain environment quality assurance period of the drug.

[0138] The temperature change properties of the drug are determined based on the temperature change properties of each drug's main component, the component ratio, and the mutual influence properties of any two drug's main components. The temperature change properties of the drug are determined by referring to formula (1):

[0139]

[0140] Among them, V mix is the temperature change property of the drug, v i is the temperature variation property of the main component of the i-th drug, p i is the proportion of the main ingredient of the i-th drug in the drug, n is the total number of main ingredients of the drug, A is the interaction matrix, A ij is the interaction property between the main components of the ith drug and the jth drug; p j is the proportion of the main ingredient of the jth drug in the drug.

[0141] The proportion of the main ingredients of a drug can be the proportion of the main ingredients that constitute the drug in the drug, and the sum of the proportions of each ingredient is 1.

[0142] Ingredient characteristics can be the physical and chemical properties of the ingredients that make up the drug.

[0143] The temperature change property can be the property that the temperature of the main component of a certain drug changes over time under certain ambient temperature conditions.

[0144] The mutual influence property can be the property that the physical and chemical properties of two drugs are changed when the main ingredients of the two drugs are mixed together in a certain proportion.

[0145] The temperature change property of a drug may be the property that the temperature of the drug changes over time under certain ambient temperature conditions.

[0146] Specifically, by querying the drug description, the main component ratio of the drug is obtained, and the chemical formula and component name of the main component of the drug are obtained according to the main component of the drug. The structural formula of the main component of the drug is determined through the component name and chemical formula, and the structural formula of the main component of the drug is analyzed to determine the number of chemical bonds and functional groups. The physical and chemical properties of the main component of the drug are determined according to the types and quantities of chemical bonds and functional groups. From the physical and chemical properties of the main component of the drug, the component characteristics of the main component of the drug can be determined, thereby determining the temperature change properties of the main component of the drug. Considering the mutual influence between the main components of the drug, when the two components are mixed, according to the structural formula of the two main components of the drug and the form of the drug, such as liquid state and capsule state, it is confirmed whether the two main components of the drug will react in the drug form. If a reaction occurs, the reaction results between the two are analyzed through the functional groups and chemical bonds contained in the structural formula of the two main components of the drug, thereby determining the mutual influence properties of the two. Finally, formula (1) is used to determine the temperature change properties of the main components of each drug, the component ratio, and the mutual influence properties of any two main components of the drug. Then, based on the temperature change properties of the drug and the temperature of the non-refrigerated area, it is determined how long it will take for the drug to deteriorate at the temperature of the non-refrigerated area, that is, to determine the non-cold chain environment quality assurance period of the drug.

[0147] Through the method provided in this embodiment, the main components of the drug are deeply analyzed, the temperature change properties of the main components of the drug are obtained, and then the mutual influence properties between the main components of the drug are obtained. By obtaining the mutual influence properties between the main components of the drug, it can help to more accurately determine the temperature change properties of the drug, and help prevent the components from reacting with each other, thereby avoiding drug safety problems. Using the designed mathematical formula, the temperature change properties of the drug are calculated based on the temperature change properties of each main component of the drug, the component ratio and the mutual influence properties of any two main components of the drug, and then the temperature change properties of the drug are combined with the non-cold chain environment temperature to provide an accurate scientific basis for obtaining the non-cold chain environment quality assurance time of the drug, which is convenient for the scheduling of drugs during subsequent loading.

[0148] In some embodiments, the geographic location information of the warehouse is obtained based on the warehouse information; the path planning information is determined based on the vehicle geographic location information and the warehouse geographic location information; the path planning information is analyzed based on the optimal vehicle information to determine the vehicle arrival time at the warehouse; and a loading strategy is formulated based on the drug information, warehouse information, the vehicle arrival time at the warehouse and the non-cold chain environment warranty time.

[0149] The warehouse geographic location information may be information revealing the geographic location of the warehouse for this loading, and the warehouse geographic location information may include latitude and longitude information.

[0150] The vehicle geographic location information may be information included in the vehicle information that discloses the location of the best vehicle participating in this loading, and the vehicle geographic location information may include latitude and longitude information.

[0151] The path planning information may be route selection information from one place to another according to certain standards. In this embodiment, the starting point of the path planning is the current location of the vehicle, and the end point of the path planning is the location of the warehouse.

[0152] Specifically, according to the warehouse information, the longitude and latitude of the warehouse are obtained, and then the geographical location information of the warehouse is determined according to the longitude and latitude. Combined with the vehicle geographical location information, the current location of the vehicle is determined as the starting point, and the location of the warehouse is determined as the end point. With the help of the third-party platform program, all feasible routes are selected. Among all feasible routes, the route with the shortest travel time is selected, and the information of this route with the shortest travel time is determined as the path planning information. Then, according to the best vehicle information, the performance index of the best vehicle is obtained. From the vehicle performance index, the speed of the best vehicle is determined. The road condition information of the route with the shortest travel time is obtained from the third-party platform. The traffic conditions of the route are judged according to the road condition information. By combining the vehicle information with the route information, the time when the vehicle arrives at the warehouse is determined. According to the time when the vehicle arrives at the warehouse, the warehouse can be prepared in advance, and the goods can be loaded immediately after the vehicle arrives, avoiding the situation of waiting too long after the vehicle arrives. The efficiency of loading goods is improved and a scientific loading strategy is formulated.

[0153] Through the method provided in this embodiment, the geographical location of the warehouse is first determined based on the warehouse information, and then the path planning information is determined based on the geographical location of the vehicle and the geographical location of the warehouse, which reduces the time the vehicle is on the road, thereby speeding up the logistics speed and improving the overall logistics efficiency. Then, based on the best vehicle information and combined with the path planning information, the actual path situation is obtained to ensure that the accurate time for the vehicle to arrive at the warehouse is obtained. According to the time the vehicle arrives at the warehouse, the warehouse can be prepared in advance to ensure that the goods can be loaded immediately after the vehicle arrives. Comprehensive drug information, warehouse information, vehicle arrival time at the warehouse and non-cold chain environment warranty time are used to formulate an efficient loading strategy, making the entire loading process more smooth.

[0154] In some embodiments, the drug delivery destination is determined based on the drug information; the vehicle transportation starting point and the vehicle transportation end point are determined based on the warehouse geographical location information and the drug delivery destination; each feasible route is determined based on the vehicle transportation starting point and the vehicle transportation end point; based on each feasible route, the route information of each feasible route is extracted; the route information is analyzed to determine the route distance and route conditions; the route conditions are analyzed to determine the route bumps; the route bumps are analyzed to determine the temperature impact of the feasible route on the drug; based on the temperature impact, the feasible routes are screened to obtain suitable routes; based on the route distance and route conditions of each suitable route, the travel time of the suitable route is determined; the route information of the suitable route with the shortest travel time is used as the transportation path planning information.

[0155] The route bumpiness may be the degree of bumpiness felt by passing vehicles on a feasible route determined by road conditions. In a specific implementation, the route bumpiness may be part of the road conditions, which may be obtained from a third-party platform. In order to avoid incorrect information on the third-party platform, the driver's historical transportation information is also used to obtain road condition information during actual transportation. The driver feeds back the road condition information they obtain to the system, and then stores the road condition information in the route database.

[0156] The impact on drug temperature may be due to road bumps, which may cause changes in the placement of drugs and heat dissipation, thereby causing changes in drug temperature.

[0157] A feasible route may be all achievable routes from the vehicle transportation starting point to the vehicle transportation end point.

[0158] A suitable route may be a route where bumpy road conditions will not have a significant impact on the drugs.

[0159] The transportation path planning information may be information about the route selected for this transportation.

[0160] Specifically, the destination of drug delivery is obtained from the drug information, and the location of the loading warehouse is used as the starting point of the vehicle transportation, and the destination of drug delivery is used as the end point of the vehicle transportation. From the third-party platform, all feasible routes and road condition information of the two places are obtained. According to the feasible routes, the distance data and road conditions are obtained, and the travel time is calculated according to the distance data and road conditions. Combined with the road condition information of the third-party platform and the road condition information in the route database, the bumps in the route are determined. By calculating how much distance is a bump-free section, how much distance is a slightly bumpy section, and how much distance is a severely bumpy section, the bumpy condition of the route is determined. According to the bumpy condition of the route, when the conditions of some sections of the route are unknown, a simple judgment can be made based on the route information.

[0161] The impact of route bumps on drug temperature is determined by analyzing the distance ratio and bumpiness of sections with no bumps, sections with slight bumps, and sections with severe bumps. For example, in a certain transportation route, the ratio of bumpy sections is required to be less than 30% (including severe bumps and slight bumps) and the severe bumps do not exceed 10%. According to the information from the third-party platform and the route database, 70% of the sections are bump-free sections, 20% are slightly bumpy sections, and the conditions of the remaining sections are unknown. The bumpiness is determined based on the road type of the remaining sections. If it is a highway section, it is a bump-free section, national highways and provincial highways are slightly bumpy sections, and county roads and township roads are severely bumpy sections. If the remaining sections are identified as severely bumpy, the sum of the severely bumpy sections and the slightly bumpy sections of this route accounts for 30% and the severe bumps account for 10%. It can be considered that the bumpiness of this route has too much impact on the temperature of the drugs and is not suitable for this transportation. The route needs to be replanned. It should be noted that the road section requirements for each transportation may be different, and the above content in this embodiment is only an example.

[0162] The routes with all road sections that meet the requirements and good bumpy conditions are determined as suitable routes, and based on the travel time of the suitable routes, the route with the shortest travel time is determined as the transportation route, and the transportation route information is determined as the transportation path planning information.

[0163] Through the method provided in this embodiment, the drug delivery destination is first obtained through the drug, and then the warehouse location is used as the transportation starting point, and the drug delivery destination is used as the transportation end point. All passable routes are screened out, and the impact of the bumps on the drug temperature is determined in combination with the bumps on the route. The route with good bumps is selected, and the transportation time is calculated based on the route distance and the route conditions. The route with the shortest transportation time is used as the transportation route. By considering the impact of the route bumps on the temperature, the situation in which the drug temperature fluctuates greatly due to route reasons and thus the quality changes during the transportation process is avoided, and a route with a shorter travel time is selected from the appropriate routes, making the entire transportation more reliable and faster, and avoiding the risk of chain breaks due to transportation route factors as much as possible, providing a scientific strategy for transportation route planning.

[0164] In some embodiments, the total personnel information and the total equipment information of the warehouse are determined based on the warehouse information; the total personnel information and the total equipment information of the warehouse are analyzed to obtain the personnel tasks and the equipment tasks; based on the personnel tasks and the equipment tasks, the personnel information and the equipment information used for this shipment are determined; the personnel information and the drug information are analyzed to determine the personnel unloading capacity; the equipment information is analyzed to determine the number and size of the devices; the warehouse shipment capacity is determined based on the personnel unloading capacity, the number and size of the devices and the size of the single drug; a loading strategy is formulated based on the personnel information, the warehouse shipment capacity, the vehicle arrival time and the warranty time in the non-cold chain environment.

[0165] Determine the warehouse outbound capacity based on the personnel unloading capacity, the number of devices, the device size and the size of the drug unit. Refer to formula (2) to determine the warehouse outbound capacity:

[0166]

[0167] Among them, B is the warehouse outbound capacity, α is the connection rate coefficient between people and equipment, C is the personnel unloading capacity, M is the number of equipment, S d is the size of a single device, S g The size of a single piece of medicine.

[0168] The total personnel information of the warehouse can be the information of all personnel in the current warehouse.

[0169] The total device information of the warehouse may be information of all devices currently in the warehouse that can be used for loading goods.

[0170] The personnel task may be a task that the personnel in the warehouse are currently participating in.

[0171] The device task may be a task that various devices in the warehouse are currently participating in.

[0172] The unloading capacity of personnel can be the minimum unloading capacity of the personnel participating in this task, and the standard for measuring the unloading capacity can be the volume and quality of the cargo.

[0173] The warehouse outbound capacity can be used to describe the warehouse's ability to unload goods from the cold storage and then move the goods to the vehicle at a speed.

[0174] Specifically, through the warehouse information, we can know how many people and equipment are in the warehouse, whether these people and equipment currently have tasks, if not, these people and equipment will be used to participate in this loading plan. For example, there are 50 people and 10 forklifts in the warehouse, but 20 people and 5 forklifts are performing other tasks, then the remaining 30 people and 5 forklifts will participate in this loading plan. The equipment can also be a lift, etc.

[0175] Based on the information of the personnel involved in the task and the information of the medicines, we analyze the personnel's unloading capacity. Based on the basic information of the equipment, we get the number and size of the equipment, and use the formula to calculate the warehouse's outbound capacity. α is the connection rate coefficient between people and equipment, which is related to the proficiency of the person and the type of equipment. It needs to be obtained through the previous actual handling situation. The highest value is 1, which represents seamless connection. For example, the people participating in this loading plan are all highly proficient employees, and the type of equipment is a small device with simple operation. Then the connection rate coefficient between people and equipment is infinitely close to 1. The larger the value of the device size is compared to the size of a single drug, The closer it is to 1, the greater the warehouse's outbound capacity. Substitute the number of devices, device size, and drug room size into formula (2) to obtain the warehouse's outbound capacity. After obtaining the outbound capacity, combine it with personnel information, vehicle arrival time, and non-cold chain environment warranty time to formulate a loading strategy.

[0176] Through the method provided in this embodiment, the total personnel information and the total equipment information of the warehouse are first obtained, and then the personnel and equipment that can be used for loading the goods this time are determined according to the task information of each personnel and each equipment, which provides a data basis for the subsequent calculation of the warehouse outbound capacity. The warehouse outbound capacity is calculated using mathematical formulas by utilizing the personnel unloading capacity, the number of equipment, and the size of the equipment in combination with the size of a single drug. The warehouse outbound capacity can be accurately grasped, which provides reasonable basic information for subsequent coordination with vehicles. According to the arrival time of the vehicle, when to start moving the goods is calculated in advance before the vehicle arrives, so that the vehicle does not wait for the goods, and the goods do not wait for the vehicle after leaving the cold storage.

[0177] In some embodiments, the weight of a single drug is determined based on drug information and packaging information; the number of people loading a single drug is determined based on the volume of a single drug, the weight of a single drug, and personnel information; the total number of people loading the drug is determined based on personnel information; and the personnel unloading capacity is determined based on the total number of people loading the drug and the number of people loading a single drug using formula (3):

[0178]

[0179] Among them, C is the unloading capacity of personnel, N is the total number of people loading goods, and n p The number of people loading a single item.

[0180] The number of people required to load a single item can be the number of people required to load a single item. This number can be less than 1, which means that one person can carry multiple items at a time.

[0181] Specifically, the unit mass of the drugs is obtained based on the drug information, and then the number of drugs in one piece is determined based on the packaging information. The quantity of drugs in one piece is determined, and the mass of a single drug piece is calculated based on the unit mass of the drugs and the quantity of drugs in one piece. The calculation method is: quantity × unit mass. Then, combined with the maximum mass and maximum volume that one person can carry, the number of people required for each piece is determined. If the drug mass and volume are too large, it may take multiple people to carry one piece at a time. If the drug mass and volume are small, one person can carry multiple pieces at a time. Then, based on the total number of people involved in loading, the unloading capacity of the personnel is determined by formula (3).

[0182] Through the method provided in this embodiment, the unit mass of the drugs is first obtained according to the drug information, and then the number of drugs in each piece is obtained through the drug packaging information, so as to determine the mass of the single drug piece. The mass of the single drug piece is combined with the volume of the single drug piece, and the human factor is taken into consideration to determine how many people are needed to load one piece of goods. This is beneficial to avoid waste of human resources and improve handling efficiency. Finally, based on the total number of people loading goods, the unloading capacity of the personnel is calculated using mathematical formulas, and the abstract handling capacity is concretized, which provides direct data for measuring the unloading capacity. Flexible arrangements can also be made for different goods, and the most reasonable personnel arrangements can be made regardless of the size and weight of the goods.

[0183] In some embodiments, the maximum volume and the maximum mass that can be carried by a single person are determined based on the personnel information; the number of people carrying a single item is determined based on the maximum volume, the maximum mass, the volume of a single item of medicine, and the mass of a single item of medicine using formula (4):

[0184]

[0185] Among them, n p is the number of people loading a single piece of goods, V max is the maximum volume that a single person can carry, v is the volume of a single medicine, M max is the maximum mass that can be carried by a single person, and m is the volume of a single piece of medicine.

[0186] Specifically, based on personnel information and taking the height and strength of the weakest person among the personnel as a benchmark, determine the maximum volume and maximum mass that a single person can carry. Excluding the influence of a single person on the maximum mass that a single person can carry, divide the maximum volume carried by a single person by the volume of a single piece of medicine and round up. Divide the maximum mass carried by a single person by the mass of a single piece of medicine and round down. The smaller value is selected as the number of people loading a single piece of goods.

[0187] The maximum volume that a person can carry can be based on the person's height. Multiply the height by the first base number as the maximum length of the medicine that can be carried, multiply the height by the second base number as the maximum width of the medicine that can be carried, and multiply the height by the third base number as the maximum height of the medicine that can be carried. The maximum carrying mass of a person needs to take muscle endurance into consideration. When there are a lot of medicines and continuous work is required, the maximum mass may be small. When the number of medicines is small, it only takes a few times to complete the handling, and the maximum mass may be large. For example, the weakest member is a male who is 170cm tall and weighs 60kg. The first cardinality is 0.6, the second cardinality is 0.3, and the third cardinality is 0.3. The maximum volume he can carry can be considered to be no more than 170cm×0.6 in length, and no more than 170cm×0.3 in width and height. Because there are many medicines, the maximum mass does not exceed 15kg. If the maximum volume of a single medicine does not exceed the maximum volume that can be carried, but the mass is 25kg, the number of people carrying a medicine is 25 / 15, rounded up to 2 people; if the maximum volume and maximum mass of a single medicine are both small, one person can carry multiple pieces. It should be noted that the cardinality is not necessarily the same for each transportation, depending on the medicine situation and personnel information. The above cardinality is only an example in this embodiment.

[0188] Through the method provided in this embodiment, firstly, the maximum volume and the maximum mass that can be carried by a single person are determined based on the personnel information, and the number of people loading each piece of medicine is obtained by taking into account the volume and mass of each piece of medicine. By using mathematical formulas, personnel can be accurately arranged, which can avoid both waste of human resources and the danger of overload of personnel.

Claims

1. A cold chain logistics warehousing intelligent management system based on big data, characterized in that: include: Obtain and analyze the stocking plan, and determine drug information and warehouse information; Analyze the drug information and determine the appropriate storage temperature; Analyze the drug information, the warehouse information and the suitable storage temperature to determine the non-cold chain environment warranty period of the drug; Determining vehicle information according to the suitable storage temperature and the drug information; According to the drug information, the warehouse information, the vehicle information and the non-cold chain environment warranty period, formulate a loading strategy for reference by cold chain logistics warehousing management personnel; The analyzing the drug information, the warehouse information and the suitable storage temperature to determine the non-cold chain environment quality assurance period of the drug includes: According to the warehouse information, non-refrigerated area information is obtained; Analyze the non-refrigerated area information to determine the temperature of the non-refrigerated area; Determine the main ingredients of the drug based on the drug information; Analyze the temperature of the non-refrigerated area, the main ingredients of the drug and the suitable storage temperature to determine the non-cold chain environment quality assurance period of the drug; The analyzing the temperature of the non-refrigerated area, the main ingredients of the drug and the suitable storage temperature to determine the non-cold chain environment quality assurance period of the drug includes: Determine the proportion of the main ingredients of the drug based on the drug information; Analyze the main components of the drug and determine the composition characteristics of each main component of the drug; Analyze the composition characteristics to determine the temperature variation properties of each major component of the drug; Based on the characteristics of the ingredients, determine whether any two main ingredients of the drug have properties that affect each other; If it exists, the temperature change property of the drug is determined according to the temperature change property of each main component of the drug, the component ratio and the mutual influence property of any two main components of the drug, referring to the following formula: Among them, V mix is the temperature change property of the drug, v i is the temperature variation property of the main component of the i-th drug, p i is the proportion of the main ingredient of the i-th drug in the drug, n is the total number of main ingredients of the drug, A is the interaction matrix, A ij is the interaction property between the main components of the ith drug and the jth drug; p j is the proportion of the main ingredient of the jth drug in the drug; Analyze the temperature of the non-refrigerated area and the temperature change properties of the medicine to determine the non-cold chain environment quality assurance period of the medicine.

2. The system according to claim 1, characterized in that The determining of vehicle information according to the suitable storage temperature and the drug information includes: According to the drug information, obtain drug quantity and drug packaging information; Determining the number of medicines according to the quantity of the medicines and the packaging information of the medicines; Determine the size of a single piece of medicine according to the medicine packaging information; The vehicle information is determined based on the number of medicines, the suitable storage temperature and the size of each medicine.

3. The system according to claim 2, characterized in that The determining of vehicle information according to the number of medicines, the suitable storage temperature and the size of each medicine includes: Determine the volume of a single medicine according to the size of the single medicine; Determining suitable storage vehicle information according to the suitable storage temperature; Determine the number of pieces loaded on each suitable storage vehicle according to the suitable storage vehicle information and the size of the medicine pieces; According to the volume of the single medicine and the number of medicines loaded on each suitable storage vehicle, the best vehicle is selected from the suitable storage vehicle information, and the best vehicle information is extracted; Determining the number of vehicles according to the number of medicines and the number of loaded medicines of the optimal vehicle; The vehicle information is determined according to the optimal vehicle information and the number of vehicles.

4. The system according to claim 3, characterized in that The vehicle information also includes the vehicle geographic location information. The formulating of a loading strategy based on the drug information, the warehouse information, the vehicle information and the non-cold chain environment warranty period includes: According to the warehouse information, obtain the warehouse geographical location information; Determining path planning information according to the vehicle geographic location information and the warehouse geographic location information; Analyze the path planning information according to the optimal vehicle information to determine the time when the vehicle arrives at the warehouse; A loading strategy is formulated based on the drug information, the warehouse information, the vehicle arrival time at the warehouse and the non-cold chain environment warranty period.

5. The system according to claim 4, characterized in that After formulating the loading strategy according to the drug information, the warehouse information, the time when the vehicle arrives at the warehouse and the non-cold chain environment warranty time, the method further includes: Determine the destination of drug delivery according to the drug information; Determine the vehicle transportation starting point and the vehicle transportation end point according to the warehouse geographical location information and the drug delivery destination; Determine each feasible route according to the vehicle transportation starting point and the vehicle transportation end point; According to each feasible route, extracting route information of each feasible route; Analyze the route information to determine the route distance and route conditions; Analyze the road conditions of the route to determine the bumpiness of the route; Analyze the bumps on the route to determine the effect of the feasible route on the temperature of the drug; According to the temperature influence, the feasible routes are screened to obtain a suitable route; Determine the travel time of the suitable route according to the route distance and route conditions of each suitable route; The route information of the suitable route with the shortest travel time is used as the transportation route planning information.

6. The system according to claim 5, characterized in that The formulating of a loading strategy according to the drug information, the warehouse information, the time when the vehicle arrives at the warehouse and the non-cold chain environment warranty time includes: According to the warehouse information, determine the total personnel information and total equipment information of the warehouse; Analyze the total personnel information and the total equipment information of the warehouse to obtain personnel tasks and equipment tasks; According to the personnel tasks and the device tasks, determine the personnel information and device information used for this shipment; Analyze the personnel information and the drug information to determine the personnel's unloading capacity; Analyze the device information to determine the number and size of devices; Determine the warehouse outbound capacity based on the personnel unloading capacity, the number of devices, the device size and the size of the drug unit, referring to the following formula: Among them, B is the warehouse outbound capacity, α is the connection rate coefficient between people and equipment, C is the personnel unloading capacity, M is the number of equipment, S d is the size of a single device, S g The size of a single piece of medicine; A loading strategy is formulated based on the personnel information, the warehouse's outbound capacity, the vehicle's arrival time, and the non-cold chain environment warranty period.

7. The system according to claim 6, characterized in that The analyzing the personnel information and the drug information to determine the personnel unloading capacity includes: Determining the quality of a single drug according to the drug information and the drug packaging information; Determine the number of people loading each item according to the volume of the item, the weight of the item and the personnel information; Determine the total number of people loading goods based on the personnel information; Determine the unloading capacity of personnel based on the total number of people loading goods and the number of people loading each piece of goods, referring to the following formula: Among them, C is the unloading capacity of personnel, N is the total number of people loading goods, and n p The number of people loading a single item.

8. The system according to claim 7, characterized in that The determining the number of people loading a single piece of medicine according to the volume of the single piece of medicine, the mass of the single piece of medicine and the personnel information includes: Determine the maximum volume and the maximum mass that can be carried by a single person based on the personnel information; According to the maximum volume, the maximum mass, the volume of a single drug item and the mass of a single drug item, determine the number of people loading a single item, referring to the following formula: Among them, n p is the number of people loading a single piece of goods, V max is the maximum volume that a single person can carry, v is the volume of a single medicine, M max is the maximum mass that can be carried by a single person, and m is the volume of a single piece of medicine.

Images